Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patients Undergoing Surgery for Colon Cancer - the PILDI Study

NCT06923787 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer

Interventions

DRUG: Lidocaine
DRUG: Placebo

Sponsor

Institute of Oncology Ljubljana